ResearcherTianjin Medical University Cancer Institute and HospitalActive in the last 2 years
Xiangqin Zhao
Matched on ORCID iD 0009-0002-0866-2765; OpenAlex author ID A5102875437. Sources: OpenAlex.
Their work
- Papers
- 3 (first author 1, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 7
2024: 2 papers · 2025: 1 paper
Papers 3
- Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer. Co-author DOI 10.3791/67413↗
- Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. First author DOI 10.1016/j.isci.2024.111085↗
- Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immune infiltration in pancreatic cancer. Co-author DOI 10.1093/jleuko/qiae067↗
Closest collaborators
The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Ying Ma · 3 shared papers, 2024–2025 · strength 0.67
- Paper Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancrea… DOI 10.3791/67413↗
- Paper Tumor-infiltrating mast cells confer resistance to immunotherapy in pancreatic cancer. DOI 10.1016/j.isci.2024.111085↗
- Paper Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immu… DOI 10.1093/jleuko/qiae067↗
- Jihui Hao · 2 shared papers, 2024–2025 · strength 0.45
- Paper Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancrea… DOI 10.3791/67413↗
- Paper Integrating tertiary lymphoid structure-associated genes into computational models to evaluate prognostication and immu… DOI 10.1093/jleuko/qiae067↗
- Huamin Wang · 1 shared paper, 2024 · strength 0.22
- Jin Zhang · 1 shared paper, 2024 · strength 0.22
- Patrick Hwu · 1 shared paper, 2024 · strength 0.22
- Baoan Ji · 1 shared paper, 2024 · strength 0.22
- Craig D. Logsdon · 1 shared paper, 2024 · strength 0.22
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.